METADATA
last updated: 2026-02-23 AI
file_name: _AI_Literature Review - RT-LAMP Large-Scale Testing and Pandemic Preparedness.md
file_date: 2026-02-23
title: FloodLAMP Literature Review - RT-LAMP Large-Scale Testing and Pandemic Preparedness
category: various
subcategory: papers-lamp
tags: rt-lamp, large-scale-testing, pandemic-preparedness, screening, literature-review
source_file_type: md
xfile_type: NA
gfile_url: https://docs.google.com/document/d/1eBTpcCDwtiveSf4OiU0KJ1U0TBswM9_BBUPJJTVXrQI
xfile_github_download_url: https://raw.githubusercontent.com/FocusOnFoundationsNonprofit/floodlamp-archive/main/various/papers/Literature%20Review%20-%20RT-LAMP%20Large-Scale%20Testing%20and%20Pandemic%20Preparedness.md
pdf_gdrive_url: NA
pdf_github_url: NA
conversion_input_file_type: NA
conversion: NA
license: CC BY 4.0 - https://creativecommons.org/licenses/by/4.0/
tokens: 3732
words: 1573
notes: Created by ChatGPT 5.2 Pro Extended during archive preparation. **NOT HUMAN VERIFIED - MAY CONTAIN ERRORS** AI-generated annotated literature review of 20 key LAMP/RT-LAMP papers relevant to large-scale testing, screening, and pandemic preparedness, covering population-scale/high-throughput approaches, scalable sample-to-answer workflows, real-world screening evaluations, multiplex respiratory panels, and foundational pandemic-era assay papers. No source files were included in context; the response was generated from the model's training data with an exclusion list of papers already in the archive.
summary_short: Literature Review - RT-LAMP Large-Scale Testing and Pandemic Preparedness surveys 20 LAMP/RT-LAMP papers prioritized for large-scale testing/screening and pandemic preparedness, organized by theme (population-scale barcoded/sequenced LAMP, scalable sample-to-answer workflows, real-world screening evaluations, variant-robust multiplex panels, and foundational pandemic-era assays), with PubMed-linked citations and importance summaries for each paper.


CONTENT

## Prompt (Verbatim)
Your task is to source the 20 most important papers related to lamp molecular testing. This is loop mediated isothermal amplification. And focus on the pandemic and forward. I'm including a list of papers I already have so don't include these and give the citations for the papers in the same format as what's here and then give a couple sentence summary of each paper and why it's important. I'll place a particular focus on tests and papers that relate to large-scale testing and screening for pandemic preparedness and response.

## Prompt (Cleaned)
Identify and annotate 20 key LAMP/RT-LAMP papers (COVID-19 pandemic through present) prioritized for large-scale testing/screening and pandemic preparedness, excluding papers already in the archive collection. Organize by theme and provide PubMed links and importance summaries for each.

**Files included in context window:**
_citations_papers-lamp.md

## AI Response (ChatGPT 5.2 Pro Extended)
Below are **20 LAMP/RT-LAMP papers (COVID-19 pandemic --> present)** that I'd prioritize for **large-scale testing/screening and pandemic preparedness**, **excluding** the papers in the list you provided.

### Population-scale & high-throughput LAMP (barcoding/sequencing/automation)

1. [Ludwig KU, Schmithausen RM, Li D, et al. LAMP-Seq enables sensitive, multiplexed COVID-19 diagnostics using molecular barcoding. *Nat Biotechnol*. 2021;39(12):1556-1562.](https://pubmed.ncbi.nlm.nih.gov/34188222/) ([PubMed][1])
   **Summary/importance:** Introduces **LAMP-Seq**, pairing **RT-LAMP with molecular barcodes** and a sequencing readout to enable massively multiplexed testing. It's important because it lays a credible technical path to **population-scale pooled testing** while maintaining molecular sensitivity. ([PubMed][1])

2. [Warneford-Thomson R, Shah PP, Lundgren P, et al. A LAMP sequencing approach for high-throughput co-detection of SARS-CoV-2 and influenza virus in human saliva. *eLife*. 2022;11:e69949.](https://pubmed.ncbi.nlm.nih.gov/35532013/) ([PubMed][2])
   **Summary/importance:** Describes **COV-ID**, combining **RT-LAMP + deep sequencing** with multi-dimensional barcoding, and demonstrates **co-detection** (SARS-CoV-2 + influenza) from saliva. It's important for preparedness because it supports **thousands of samples per sequencing run** and **multiplex pathogen surveillance** in one workflow. ([PubMed][2])

3. [Peto L, et al. Diagnosis of SARS-CoV-2 Infection with LamPORE, a High-Throughput Platform Combining Loop-Mediated Isothermal Amplification and Nanopore Sequencing. *J Clin Microbiol*. 2021;59(6):e03271-20.](https://pubmed.ncbi.nlm.nih.gov/33782112/) ([PubMed][3])
   **Summary/importance:** Clinically evaluates **LamPORE** (RT-LAMP + nanopore sequencing) against RT-PCR on respiratory samples, emphasizing throughput potential on a single instrument. It's important because it's one of the clearer **clinical performance + high-throughput** demonstrations of sequencing-readout RT-LAMP. ([PubMed][3])

4. [Dewhurst RE, et al. Validation of a rapid, saliva-based, and ultra-sensitive SARS-CoV-2 screening system for pandemic-scale infection surveillance. *Sci Rep*. 2022;12(1):5936.](https://pubmed.ncbi.nlm.nih.gov/35395856/) ([PubMed][4])
   **Summary/importance:** Presents an **automated high-throughput saliva RT-LAMP surveillance system** built around the "Sentinel" instrument. It's important because it explicitly targets **pandemic-scale operations** (rapid turnaround, continuous-flow sample handling, very high throughput) rather than small-batch lab demonstrations. ([PubMed][4])

5. [Lou D, Meurer M, Ovchinnikova S, et al. Scalable RT-LAMP-based SARS-CoV-2 testing for infection surveillance with applications in pandemic preparedness. *EMBO Rep*. 2023;24(5):e57162.](https://pubmed.ncbi.nlm.nih.gov/36951170/) ([PubMed][5])
   **Summary/importance:** Provides SOPs + software/logistics for a **gargle-based RT-LAMP testing station**, reporting real-world operation at **>35,000 tests** with rapid turnaround. It's important because it's a rare "end-to-end" blueprint for deploying **scalable LAMP diagnostics** with operational constraints (costs, logistics, reporting) addressed head-on. ([PubMed][5])

### Scalable sample-to-answer LAMP workflows (saliva/gargle/paper)

6. [Lalli MA, Langmade JS, Chen X, et al. Rapid and Extraction-Free Detection of SARS-CoV-2 from Saliva by Colorimetric Reverse-Transcription Loop-Mediated Isothermal Amplification. *Clin Chem*. 2021;67(2):415-424.](https://pubmed.ncbi.nlm.nih.gov/33098427/) ([PubMed][6])
   **Summary/importance:** Optimizes **extraction-free saliva** pretreatment and colorimetric RT-LAMP (with multiple readout modes) and validates on clinical saliva. It's important because **extraction-free saliva** is a cornerstone of low-cost, high-throughput screening, and this paper became a key reference workflow for many scale-up efforts. ([PubMed][6])

7. [Bokelmann L, Nickel O, Maricic T, et al. Point-of-care bulk testing for SARS-CoV-2 by combining hybridization capture with improved colorimetric LAMP. *Nat Commun*. 2021;12(1):1467.](https://pubmed.ncbi.nlm.nih.gov/33674580/) ([PubMed][7])
   **Summary/importance:** Introduces **Cap-iLAMP** (capture + improved RT-LAMP) using gargle lavage, plus **smartphone-based hue scoring** to manage readout variability. It's important for scale because it directly addresses **false positives/specificity** and demonstrates **pooling concepts** that reduce per-person reagent cost for screening. ([PubMed][7])

8. [Yu AD, Galatsis K, Zheng J, et al. Development of a Saliva-Optimized RT-LAMP Assay for SARS-CoV-2. *J Biomol Tech*. 2021;32(3):102-113.](https://pubmed.ncbi.nlm.nih.gov/35027868/) ([PubMed][8])
   **Summary/importance:** Improves practical saliva RT-LAMP deployment by validating a higher-contrast dye and introducing **SalivaBeads** (rapid bead purification) plus a low-cost **StickLAMP** tool to simplify scalable handling. It's important because these are **implementation-enabling** innovations that make saliva RT-LAMP more robust outside highly automated labs. ([PubMed][8])

9. [Kundrod KA, Natoli ME, Chang MM, et al. Sample-to-answer, extraction-free, real-time RT-LAMP test for SARS-CoV-2 in nasopharyngeal, nasal, and saliva samples: Implications and use for surveillance testing. *PLoS One*. 2022;17(2):e0264130.](https://pubmed.ncbi.nlm.nih.gov/35213596/) ([PubMed][9])
   **Summary/importance:** Develops a **sample-to-answer**, extraction-free **real-time RT-LAMP** assay validated across **multiple sample types** (NP, nasal, saliva), explicitly framed for **surveillance testing**. It's important because surveillance programs often need flexibility in collection type and workflow simplicity to sustain frequent testing. ([PubMed][9])

10. [Wei S, Suryawanshi H, Djandji A, et al. Field-deployable, rapid diagnostic testing of saliva for SARS-CoV-2. *Sci Rep*. 2021;11(1):5448.](https://pubmed.ncbi.nlm.nih.gov/33750853/) ([PubMed][10])
    **Summary/importance:** Demonstrates a **field-deployable saliva RT-LAMP** approach aimed at minimal infrastructure while still supporting rapid detection. It's important for preparedness because outbreaks frequently require **decentralized testing** when centralized PCR capacity or extraction reagents are constrained. ([PubMed][10])

11. [Davidson JL, Wang J, Maruthamuthu MK, et al. A paper-based colorimetric molecular test for SARS-CoV-2 in saliva. *Biosens Bioelectron X*. 2021;9:100076.](https://pubmed.ncbi.nlm.nih.gov/34423284/) ([PubMed][11])
    **Summary/importance:** Builds a **paper-based** colorimetric RT-LAMP molecular test compatible with saliva, pushing toward low-cost, distributed deployment. It's important because paper-based formats are a credible route to **simplified logistics and scalable access**, particularly for low-resource or community settings. ([PubMed][11])

### Real-world performance & screening-focused evaluations

12. [Brown B, O'Hara RW, Guiver M, et al. Evaluation of a novel direct RT-LAMP assay for the detection of SARS-CoV-2 from saliva samples in asymptomatic individuals. *J Clin Virol Plus*. 2022;2(2):100074.](https://pubmed.ncbi.nlm.nih.gov/35345440/) ([PubMed][12])
    **Summary/importance:** Evaluates **direct saliva RT-LAMP** specifically in **asymptomatic** individuals -- exactly the use-case for proactive screening. It's important because asymptomatic screening is where test speed and simplicity matter most, and real-world evaluation data are essential for deciding if/where LAMP fits in a preparedness toolkit. ([PubMed][12])

13. [Kidd SP, et al. Reverse-Transcription Loop-Mediated Isothermal Amplification Has High Accuracy for Detecting Severe Acute Respiratory Syndrome Coronavirus 2 in Saliva and Nasopharyngeal/Oropharyngeal Swabs from Asymptomatic and Symptomatic Individuals. *J Mol Diagn*. 2022;24(4):320-336.](https://pubmed.ncbi.nlm.nih.gov/35121140/) ([PubMed][13])
    **Summary/importance:** Assesses RT-LAMP accuracy across **saliva and NP/OP swabs**, spanning symptomatic and asymptomatic groups. It's important because mass screening requires performance evidence across **specimen types and clinical presentations**, not just contrived samples. ([PubMed][13])

14. [Allsopp RC, Cowley CM, Barber RC, et al. A rapid RT-LAMP SARS-CoV-2 screening assay for collapsing asymptomatic COVID-19 transmission. *PLoS One*. 2022;17(9):e0273912.](https://pubmed.ncbi.nlm.nih.gov/36048856/) ([PubMed][14])
    **Summary/importance:** Frames RT-LAMP explicitly as a **screening tool** to reduce asymptomatic spread and documents an operational screening approach. It's important because it focuses on **public health impact and screening cadence**, not only analytical sensitivity. ([PubMed][14])

15. [Susnjar U, et al. Colorimetric RT-LAMP for SARS-CoV-2 detection from nasopharyngeal swabs or crude saliva: a multicountry diagnostic accuracy study in Africa. *Lancet Glob Health*. 2025;13(7):e1258-e1267.](https://pubmed.ncbi.nlm.nih.gov/40580991/) ([PubMed][15])
    **Summary/importance:** Large **multicountry diagnostic accuracy** evaluation of colorimetric RT-LAMP using **NP swabs and crude saliva** in African settings. It's important for preparedness because it provides higher-confidence evidence in **resource-variable, real-world contexts** where supply chains and infrastructure constraints are most acute. ([PubMed][15])

### Preparedness-forward: variants, robustness, and multiplex respiratory panels

16. [Dong Y, Zhao Y, Li S, et al. Multiplex, Real-Time, Point-of-Care RT-LAMP for SARS-CoV-2 Detection Using the HFman Probe. *ACS Sens*. 2022;7(3):730-739.](https://pubmed.ncbi.nlm.nih.gov/35192340/) ([PubMed][16])
    **Summary/importance:** Develops a **multiplex real-time RT-LAMP** approach using the HFman probe to support point-of-care detection with improved specificity/interpretability. It's important because more robust signal discrimination and multi-target design help assays stay useful as **variants and assay-interference risks** evolve. ([PubMed][16])

17. [Jee H, Park S, Lee J, et al. Comparative Clinical Evaluation of a Novel FluA/FluB/SARS-CoV-2 Multiplex LAMP and Commercial FluA/FluB/SARS-CoV-2/RSV RT-qPCR Assays. *Diagnostics (Basel)*. 2023;13(8):1432.](https://pubmed.ncbi.nlm.nih.gov/37189533/) ([PubMed][17])
    **Summary/importance:** Clinically evaluates a **multiplex LAMP** assay that differentiates influenza A/B and SARS-CoV-2, benchmarked against a commercial RT-qPCR respiratory panel. It's important because pandemic preparedness increasingly means **multiplex respiratory surveillance** (distinguishing pathogens quickly to guide response and clinical management). ([PubMed][17])

### Foundational pandemic-era RT-LAMP assay papers that shaped downstream scale-up

18. [Yan C, Cui J, Huang L, et al. Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay. *Clin Microbiol Infect*. 2020;26(6):773-779.](https://pubmed.ncbi.nlm.nih.gov/32276116/) ([PubMed][18])
    **Summary/importance:** One of the earliest clinical demonstrations of **rapid, visual RT-LAMP** for SARS-CoV-2 detection. It's important because it helped establish RT-LAMP as a serious alternative molecular modality when PCR capacity was constrained -- setting the stage for later scale-up and screening studies. ([PubMed][18])

19. [Park GS, Ku K, Baek SH, et al. Development of Reverse Transcription Loop-Mediated Isothermal Amplification Assays Targeting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). *J Mol Diagn*. 2020;22(6):729-735.](https://pubmed.ncbi.nlm.nih.gov/32276051/) ([PubMed][19])
    **Summary/importance:** Develops and evaluates RT-LAMP assays/primer sets for SARS-CoV-2 early in the pandemic, including practical readouts. It's important because these assay designs and evaluation approaches became foundational references that many later **saliva, extraction-free, and scaled workflows** built upon or compared against. ([PubMed][19])

20. [Ganguli A, Mostafa A, Berger J, et al. Rapid isothermal amplification and portable detection system for SARS-CoV-2. *Proc Natl Acad Sci U S A*. 2020;117(37):22727-22735.](https://pubmed.ncbi.nlm.nih.gov/32868442/) ([PubMed][20])
    **Summary/importance:** Demonstrates RT-LAMP paired with a **portable cartridge + smartphone-based reader**, showing feasibility of molecular testing without conventional lab infrastructure. It's important for preparedness because large-scale response needs both centralized high-throughput testing **and** credible point-of-collection molecular options for remote, outbreak, or surge contexts. ([PubMed][20])

[1]: https://pubmed.ncbi.nlm.nih.gov/34188222/
[2]: https://pubmed.ncbi.nlm.nih.gov/35532013/
[3]: https://pubmed.ncbi.nlm.nih.gov/33782112/
[4]: https://pubmed.ncbi.nlm.nih.gov/35395856/
[5]: https://pubmed.ncbi.nlm.nih.gov/36951170/
[6]: https://pubmed.ncbi.nlm.nih.gov/33098427/
[7]: https://pubmed.ncbi.nlm.nih.gov/33674580/
[8]: https://pubmed.ncbi.nlm.nih.gov/35027868/
[9]: https://pubmed.ncbi.nlm.nih.gov/35213596/
[10]: https://pubmed.ncbi.nlm.nih.gov/33750853/
[11]: https://pubmed.ncbi.nlm.nih.gov/34423284/
[12]: https://pubmed.ncbi.nlm.nih.gov/35345440/
[13]: https://pubmed.ncbi.nlm.nih.gov/35121140/
[14]: https://pubmed.ncbi.nlm.nih.gov/36048856/
[15]: https://pubmed.ncbi.nlm.nih.gov/40580991/
[16]: https://pubmed.ncbi.nlm.nih.gov/35192340/
[17]: https://pubmed.ncbi.nlm.nih.gov/37189533/
[18]: https://pubmed.ncbi.nlm.nih.gov/32276116/
[19]: https://pubmed.ncbi.nlm.nih.gov/32276051/
[20]: https://pubmed.ncbi.nlm.nih.gov/32868442/